Cormier Monique J, Desmeules Simon, St-Onge Maude, Ghannoum Marc
Verdun Hospital, Université de Montréal, Montréal, Quebec, Canada.
Centre Hospitalier Universitaire de Québec, Quebec, Canada.
Hemodial Int. 2017 Jan;21(1):E13-E17. doi: 10.1111/hdi.12475. Epub 2016 Sep 6.
We describe the case of a 52-year-old man who presented after having ingested an unknown quantity of phenytoin. Peak phenytoin concentration was 51.2 mg/L (therapeutic range 10-20 mg/L). Five days after admission, the patient became comatose and was intubated. Because of persistent toxic phenytoin levels and unchanged clinical status for 12 days, hemodialysis (HD) was prescribed to enhance elimination of phenytoin. HD was performed using a Gambro Theralite filter (Baxter International Inc., Deerfield, USA), a high cut-off filter that allows the removal of molecules of up to 45 kDa. Phenytoin concentration readily decreased during the 8-hour HD treatment from 38.9 mg/L to 27.8 mg/L (28.5% decrease); during HD, phenytoin half-life was 18.5h (compared to 1109.8h before HD and 56.3h after HD), phentyoin clearance averaged 80.1 mL/min and a total of 1.1 g of phenytoin was removed. Albumin removal from the Theralite filter was most important at the beginning of HD. The high clearance of phenytoin obtained with this filter was likely due to its high surface area rather than its capacity to remove the albumin-phenytoin complex.
我们描述了一名52岁男性的病例,该患者摄入了未知量的苯妥英后前来就诊。苯妥英的峰值浓度为51.2mg/L(治疗范围为10 - 20mg/L)。入院五天后,患者昏迷并接受了插管。由于苯妥英的毒性水平持续存在且临床状态在12天内未改变,因此开了血液透析(HD)来增强苯妥英的清除。使用金宝Theralite滤器(美国迪尔菲尔德的百特国际公司)进行血液透析,这是一种高截留滤器,可去除高达45kDa的分子。在8小时的血液透析治疗期间,苯妥英浓度从38.9mg/L迅速降至27.8mg/L(下降了28.5%);在血液透析期间,苯妥英的半衰期为18.5小时(相比血液透析前的1109.8小时和血液透析后的56.3小时),苯妥英清除率平均为80.1mL/min,共清除了1.1g苯妥英。在血液透析开始时,从Theralite滤器中清除白蛋白最为重要。用这种滤器获得的苯妥英高清除率可能是由于其高表面积,而不是其去除白蛋白 - 苯妥英复合物的能力。